Daunorubicin and Cytarabine (Liposomal) and Remifentanil Intravenous
Determining the interaction of Daunorubicin and Cytarabine (Liposomal) and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal)
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin and Cytarabine (Liposomal)-Reminyl
- Daunorubicin and Cytarabine (Liposomal)-Reminyl ER
- Daunorubicin and Cytarabine (Liposomal)-Remodulin
- Daunorubicin and Cytarabine (Liposomal)-Remodulin injection
- Daunorubicin and Cytarabine (Liposomal)-Remular-S
- Daunorubicin and Cytarabine (Liposomal)-Renacidin
- Remifentanil Intravenous-Daunorubicin and cytarabine liposome Intravenous
- Remifentanil Intravenous-Daunorubicin citrate
- Remifentanil Intravenous-Daunorubicin citrate liposome Intravenous
- Remifentanil Intravenous-Daunorubicin hydrochloride
- Remifentanil Intravenous-Daunorubicin Intravenous
- Remifentanil Intravenous-DaunoXome